Suppression of CNS Autoimmune Disease by TH2 Cells


NIH 2005 R01 NS	Suppression of CNS Autoimmune Disease by Th2 Cells Stohlman, Stephen A. / University of Southern California	$230,750
NIH 2005 R01 NS	Suppression of CNS Autoimmune Disease by Th2 Cells Stohlman, Stephen A. / Cleveland Clinic Lerner	$78,000
NIH 2004 R01 NS	Suppression of CNS Autoimmune Disease by Th2 Cells Stohlman, Stephen A. / University of Southern California	$308,750
NIH 2003 R01 NS	Suppression of CNS Autoimmune Disease by Th2 Cells Stohlman, Stephen A. / University of Southern California	$308,750
NIH 2002 R01 NS	Suppression of CNS Autoimmune Disease by Th2 Cells Stohlman, Stephen A. / University of Southern California	$308,750
NIH 2000 R01 NS	Suppression of CNS Autoimmune Disease by TH2 Cells Stohlman, Stephen A. / University of Southern California	$258,157
NIH 1999 R01 NS	Suppression of CNS Autoimmune Disease by TH2 Cells Stohlman, Stephen A. / University of Southern California
NIH 1998 R01 NS	Suppression of CNS Autoimmune Disease by TH2 Cells Stohlman, Stephen A. / University of Southern California
NIH 1997 R01 NS	Suppression of CNS Autoimmune Disease by TH2 Cells Stohlman, Stephen A. / University of Southern California
NIH 1996 R01 NS	Suppression of CNS Autoimmune Disease by TH2 Cells Stohlman, Stephen A. / University of Southern California

Hindinger, Claudia; Hinton, David R; Kirwin, Stefanie J et al. (2006) Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 84:1225-34

Dowdell, Kennichi C; Cua, Daniel J; Kirkman, Erlinda et al. (2003) NK cells regulate CD4 responses prior to antigen encounter. J Immunol 171:234-9